A Novel Model of Glioblastoma Recurrence to Identify Therapeutic Vulnerabilities

Researchers designed and characterized a novel induced-recurrence model in which mice xenografted with primary patient-derived glioma initiating/stem cells are treated with a therapeutic regimen closely recapitulating patient standard of care, followed by monitoring until tumours recur.